DOI:

Complete removal of extensive right coronary artery thrombus by the use of an aspiration catheter to facilitate primary angioplasty

Ajay K. Jain, BSC, MRCP; R. Andrew Archbold*, MD, MRCP

A 67 year old man with a one-hour history of chest pain due to acute inferior ST elevation myocardial infarction underwent coronary angiography after treatment with aspirin 300 mg, clopidogrel 600 mg, and a weight-adjusted abciximab bolus. The culprit lesion was a proximal occlusion of the right coronary artery (panel A). Passage of a 0.014” angioplasty wire through the occlusion restored TIMI I antegrade flow, which revealed a severe stenosis in the proximal right coronary artery (RCA) in association with a large thrombus extending to the acute margin (panel B). Angiographically visible thrombus was completely removed by the use of an aspiration catheter (Export Catheter, Medtronic, USA) (panel C). The stenosis was then stented with a 5.0 x 20 mm Liberte™ (Boston Scientific, USA) stent with no angiographic evidence of distal embolisation or no-reflow (panel D). The patient was discharged 48 hours later.

A large thrombus burden in the infarct-related artery poses technical and therapeutic challenges during percutaneous coronary intervention. Furthermore, its presence is associated with adverse angiographic and clinical outcomes. Conventional management employs combination antiplatelet therapy that includes an infusion of a glycoprotein IIb/IIIa receptor inhibitor, but the role of mechanical thrombectomy devices remains contentious. These images demonstrate that the use of an aspiration catheter can dramatically reduce thrombus load in these patients. This facilitates the procedure through better visualisation of the lesion, allowing appropriate stent selection, and it may reduce the propensity to no-reflow. Whether or not there is a clinical advantage from the use of such devices, however, remains to be determined.

Volume 3 Number 1
May 22, 2007
Volume 3 Number 1
View full issue


Key metrics

Suggested by Cory

Debate

10.4244/EIJ-E-25-00009 Jun 16, 2025
Guideline recommendations for QFR should be revisited: pros and cons
Fearon W and Biscaglia S

Flashlight

10.4244/EIJ-D-24-00795 Jun 16, 2025
Transcaval transcatheter aortic valve implantation via left-sided venous access
Doyle C and Casserly I

Letter to the editor

10.4244/EIJ-D-25-00325 Jun 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Laudani C et al
free

Letter to the editor

10.4244/EIJ-D-25-00197 Jun 16, 2025
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Sticchi A and Biondi-Zoccai G
free

Research Correspondence

10.4244/EIJ-D-24-01048 Jun 16, 2025
Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Zendo Y et al
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
42

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved